Published in Gut on May 01, 1995
Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication. Gastroenterol Res Pract (2012) 1.12
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model. Antimicrob Agents Chemother (2003) 1.07
The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin. Aliment Pharmacol Ther (2012) 0.92
Diagnostic methods for Helicobacter pylori detection and eradication. Br J Clin Pharmacol (2003) 0.81
Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole. Acta Pharmacol Sin (2010) 0.75
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet (1984) 7.45
Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.94
The who's and when's of therapy for Helicobacter pylori. Am J Gastroenterol (1990) 1.79
Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. Scand J Gastroenterol Suppl (1988) 1.77
Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol (1989) 1.74
Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol (1988) 1.24
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther (1992) 1.02
Two-week eradication regimen for metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther (1993) 0.98
Detection of Helicobacter pylori DNA by PCR in gastrointestinal equipment. Lancet (1993) 0.90
Short report: high-dose omeprazole and amoxycillin in the treatment of Helicobacter pylori-associated duodenal ulcer. Aliment Pharmacol Ther (1993) 0.86
Short report: cefprozil for the eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (1992) 0.79
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med (1998) 3.96
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology (1985) 3.12
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med (1996) 2.37
Safety of complementary medicines should be monitored. BMJ (1995) 2.27
The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl (1999) 2.20
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology (1996) 2.13
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12
agr expression precedes escape of internalized Staphylococcus aureus from the host endosome. Infect Immun (2001) 2.11
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet (1993) 2.10
Recurrent gastrointestinal bleeding of obscure origin: report of 17 cases and a guide to logical management. Br J Surg (1983) 2.09
The urea breath test for Helicobacter pylori. Gut (1994) 2.07
The clinical relevance of strain types of Helicobacter pylori. Gut (1997) 1.99
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ (1994) 1.99
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Prescribing in the UK. Lancet (2001) 1.93
Use of ethanol-induced tumor necrosis to palliate dysphagia in patients with esophagogastric cancer. Gastrointest Endosc (1990) 1.91
Journals should see original protocols for clinical trials. BMJ (2001) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.82
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs (1998) 1.74
Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol (1997) 1.70
Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol (1999) 1.69
The outer membrane of Treponema pallidum: biological significance and biochemical properties. J Gen Microbiol (1985) 1.68
Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus. Mol Microbiol (2001) 1.65
Colonic angiodysplasia and true diverticula: is there an association? Histopathology (2005) 1.62
SirR, a novel iron-dependent repressor in Staphylococcus epidermidis. Infect Immun (1998) 1.60
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology (1997) 1.59
High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut (1991) 1.58
Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci (Lond) (1992) 1.53
Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI. Am J Physiol Gastrointest Liver Physiol (2001) 1.50
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther (2010) 1.48
Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut (2002) 1.47
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy (2010) 1.44
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am J Physiol (1999) 1.42
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother (1997) 1.41
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia. Aliment Pharmacol Ther (1999) 1.40
Ileo-caecal ulceration associated with the use of diclofenac slow release. Aliment Pharmacol Ther (1993) 1.40
Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun (1992) 1.39
Somatostatin in treatment of haematemesis and melaena. Lancet (1985) 1.39
The Prader-Willi syndrome with a 15/15 translocation. Case report and review of the literature. J Med Genet (1976) 1.38
Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus. Infect Immun (2000) 1.37
Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut (1983) 1.37
Prostaglandins and ulcerative colitis. Gut (1984) 1.36
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther (2002) 1.35
The endoscopically abnormal duodenum in patients with dyspepsia: biopsy findings in 60 cases. Histopathology (1983) 1.34
An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol (2003) 1.34
Inhibition of prostaglandin synthetase in human rectal mucosa. Gut (1983) 1.32
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther (2005) 1.32
Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer (2009) 1.32
Intravenous omeprazole rapidly raises intragastric pH. Gut (1985) 1.31
Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene (1990) 1.31
High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis. Endoscopy (2011) 1.30
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut (1992) 1.30
Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol (1996) 1.30
Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. J Clin Microbiol (1999) 1.28
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther (2005) 1.27
Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer. Gut (1986) 1.27
Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology (1986) 1.26
Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Ther (2007) 1.25
The effect of omeprazole on gastric juice viscosity, pH and bacterial counts. Aliment Pharmacol Ther (1996) 1.24
Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology. Endoscopy (2008) 1.24
Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination. Curr Microbiol (1999) 1.23
Jejunal water and electrolyte absorption from two proprietary enteral feeds in man: importance of sodium content. Gut (1987) 1.21
Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease. Gut (1983) 1.21
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol (1997) 1.21
Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut (1998) 1.20
Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ (1989) 1.18
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. J Gen Microbiol (1985) 1.16
Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol (1990) 1.16
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) (1999) 1.16
Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci (1985) 1.16
Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut (2000) 1.15
A national training programme for gastroenterology and hepatology. Gut (1996) 1.14
The axial filament antigen of Treponema pallidum. Immunology (1985) 1.14
Histopathological detection of lymph node metastases from colorectal carcinoma. J Clin Pathol (2000) 1.14
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther (2001) 1.13
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther (1999) 1.13
A flagellar sheath protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGS cells. J Bacteriol (1997) 1.13
Pathogenesis of colonic diverticula. Br J Surg (2002) 1.10
Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut (1995) 1.09
Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2006) 1.09
Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol (1991) 1.08
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther (1999) 1.08
Misoprostol, smoking, and duodenal ulcer healing rates. Lancet (1987) 1.08
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther (1998) 1.07
Non-invasive quantification of small bowel water content by MRI: a validation study. Phys Med Biol (2007) 1.07
Proposed pathogenic mechanism for the diarrhea associated with human intestinal spirochetes. Am J Clin Pathol (1986) 1.07
Intraventricular neurocytoma: a clinical and pathological study of three cases and review of the literature. Neurosurgery (1990) 1.07
Gastric response to increased meal viscosity assessed by echo-planar magnetic resonance imaging in humans. J Nutr (2000) 1.06
The Staphylococcus aureus and Staphylococcus epidermidis transferrin-binding proteins are expressed in vivo during infection. Microbiology (1998) 1.06